0001181431-12-052226.txt : 20120927 0001181431-12-052226.hdr.sgml : 20120927 20120927184327 ACCESSION NUMBER: 0001181431-12-052226 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120925 FILED AS OF DATE: 20120927 DATE AS OF CHANGE: 20120927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adams Daniel CENTRAL INDEX KEY: 0001328448 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 121114189 MAIL ADDRESS: STREET 1: 501 SECOND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 4 1 rrd356935.xml SEPTEMBER 2012 -- EXERCISE AND SALE X0306 4 2012-09-25 0 0001011835 MEDIVATION, INC. MDVN 0001328448 Adams Daniel C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 1 0 0 0 Common Stock 2012-09-25 4 M 0 5000 6.97 A 5000 D Common Stock 2012-09-25 4 S 0 5000 55.0017 D 0 D Common Stock 2012-09-27 4 M 0 23038 6.97 A 23038 D Common Stock 2012-09-27 4 M 0 60000 9.38 A 83038 D Common Stock 2012-09-27 4 S 0 83038 55.7305 D 0 D Stock Option (Right to Buy) 6.97 2012-09-25 4 M 0 5000 0.00 D 2018-06-15 Common Stock 5000 23038 D Stock Option (Right to Buy) 6.97 2012-09-27 4 M 0 23038 0.00 D 2018-06-15 Common Stock 23038 0 D Stock Option (Right to Buy) 9.38 2012-09-27 4 M 0 60000 0.00 D 2017-06-14 Common Stock 60000 0 D Shares were sold pursuant to a 10b5-1 Plan. The shares were sold at prices ranging from $55.00 to $55.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. This option was previously reported but has been adjusted here to reflect the 2-for-1 stock split of the issuer's common stock that occurred on September 21, 2012. Fully Vested The shares were sold at prices ranging from $55.52 to $56.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Patrick Machado, Attorney-in-fact 2012-09-27